You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5346 Results
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
New Drug Funding Program
    Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Sep 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Sep 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Funding:
New Drug Funding Program
    Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Sep 2025
The Population Health and Prevention Unit creates high-quality information, tools and policy recommendations that focus on modifiable risk factors...
L'Unité de la santé de la population et de la prévention élabore de l'information de grande qualité, des instruments et des recommandations...
La perturbation du service de Postes Canada pourrait avoir une influence sur la livraison des lettres de dépistage du cancer et des trousses de tests...
Drug
Other Name(s): Welireg®
Updated
Sep 2025
Drug
Other Name(s): Akeega™
Updated
Sep 2025
Drug
Other Name(s): Reblozyl®
Updated
Sep 2025
Drug
Other Name(s): Blincyto®
Updated
Sep 2025
Drug
Other Name(s): Camptosar®
Updated
Sep 2025
Drug
Other Name(s): Imbruvica®
Updated
Sep 2025

Pages